Susan Bal, MD

Susan Bal, MD, is an assistant professor, hematology, medical oncology, at the University of Alabama at Birmingham (UAB), UAB Health, O’Neal Comprehensive Cancer Center.

Articles by Susan Bal, MD

Arlo-Cel Shows Promise in Early-Line Relapsed Multiple Myeloma

BySusan Bal, MD

June 18th 2026

Susan Bal, MD, discusses outcomes with arlo-cel, a GPRC5D-targeted CAR T product in relapsed/refractory multiple myeloma.

Bal on Targeting GPRC5D in R/R Multiple Myeloma

BySusan Bal, MD

December 22nd 2023

Susan Bal, MD, discusses novel targets for relapsed/refractory multiple myeloma at the 2023 Annual Meeting.

Susan Bal, MD

Articles by Susan Bal, MD

Arlo-Cel Shows Promise in Early-Line Relapsed Multiple Myeloma

Bal on Targeting GPRC5D in R/R Multiple Myeloma

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival

Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma

Safusidenib Shows Durable Responses in IDH1-Mutant Glioma at 3-Year Follow-Up

Thoracic Radiotherapy Added to Atezolizumab Raised Toxicity in SCLC

CheckMate 9LA Data Push Toward Dual Checkpoint Blockade in PD-L1–Negative NSCLC